Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
bluebird bio, Inc. (BLUE)
|
Add to portfolio |
|
|
|
| Price: |
$10.60
| | Metrics |
| OS: |
107.0
|
M
| |
|
|
| Market cap: |
$1.13
|
B
| |
|
|
|
Net cash:
|
$245
|
M
| |
$2.29
|
per share
|
|
EV:
|
$888
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 3.7 | 0.0 | 0.0 | 54.6 | 54.6 | 35.4 | 6.2 | 14.1 |
| Revenue growth | | | -100.0% | 54.1% | | 475.6% | -56.3% | -44.6% |
| Cost of goods sold | 38.9 | 0.0 | 0.0 | 0.9 | 0.0 | 1.5 | 0.0 | 0.0 |
| Gross profit | -35.2 | 0.0 | 0.0 | 53.7 | 54.6 | 33.9 | 6.2 | 14.1 |
| Gross margin | -961.1% | | | 98.4% | 100.0% | 95.7% | 100.0% | 100.0% |
| Selling, general and administrative | 210.0 | 240.0 | 235.8 | 174.1 | 174.1 | 93.6 | | |
| Research and development | 319.9 | 319.3 | 327.1 | 448.6 | | 273.0 | 204.8 | 134.0 |
| General and administrative | | | | | | | 65.1 | 46.2 |
| EBITA | -564.7 | -558.8 | -562.7 | -565.2 | -569.0 | -328.9 | -263.7 | -169.0 |
| EBITA margin | -15420.8% | | | -1035.6% | -1042.6% | -928.4% | -4285.0% | -1200.6% |
| Amortization of intangibles | 0.4 | 0.5 | 0.3 | 3.8 | | 3.8 | | |
| EBIT | -565.1 | -559.3 | -563.0 | -569.0 | -569.0 | -332.7 | -263.7 | -169.0 |
| EBIT margin | -15431.7% | | | -1042.6% | -1042.6% | -939.1% | -4285.0% | -1200.6% |
| Pre-tax income | -562.4 | -560.4 | -555.6 | -555.4 | -555.4 | -335.4 | -264.1 | -166.7 |
| Income taxes | 0.3 | 0.7 | -0.5 | 0.2 | 0.2 | 0.2 | -0.6 | 0.1 |
| Tax rate | | | 0.1% | | | | 0.2% | |
| Net income | -819.4 | -618.7 | -789.6 | -555.6 | -555.6 | -335.6 | -263.5 | -166.8 |
| Net margin | -22375.2% | | | -1018.0% | -1018.0% | -947.4% | -4281.2% | -1184.6% |
| |
| Diluted EPS | ($8.16) | ($9.02) | ($10.06) | ($10.68) | | ($7.71) | ($7.07) | ($4.81) |
| Shares outstanding (diluted) | 68.9 | 62.2 | 55.2 | 52.0 | | 43.5 | 37.3 | 34.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|